Researcher
Thierry Vandendriessche
- Keywords (Vrije Universiteit Brussel):Medicine, Applied biological sciences, biotechnology
- Disciplines (Vrije Universiteit Brussel):Hematology, Neurological and neuromuscular diseases, Cancer therapy, Cardiology, Computational transcriptomics and epigenomics
- Disciplines (KU Leuven):Gene and molecular therapy
- See also: Thierry VandenDriessche (Vrije Universiteit Brussel)
Affiliations
- Division of Gene Therapy & Regenerative Medicine (Research group)
Responsible
From19 Apr 2011 → Today - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Cell Biology and Histology (Department)
Member
From1 Oct 2010 → 31 Dec 2013 - Department of Bio-engineering Sciences (Department)
Member
From1 Feb 2010 → 28 Feb 2010 - Immunology and Microbiology (Department)
Member
From1 Oct 2007 → 30 Sep 2010 - Department of Bio-engineering Sciences (Department)
Member
From1 Feb 2007 → 30 Sep 2010 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 2003 → 30 Sep 2004 - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → Today - Department of General Biology (Research group)
Member
From1 Oct 1990 → 30 Sep 1994
Projects
1 - 3 of 3
- Development of stem cell-based gene therapy for Duchenne muscular dystrophy.From27 Sep 2010 → 16 Jun 2016Funding: FWO fellowships
- Role of microRNA in controlling hepatic carcinogeneis: in vivo validation, mechanisms and therapeutic implications.From1 Jan 2010 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
- Role of micro-RNA in cardiac hypertrophy: fundamental and therapeutic implications.From1 Jan 2009 → 31 Dec 2011Funding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 141
- Gene and Cell Therapy: Tearing Down Walls(2018)
Authors: Thierry Vandendriessche
Pages: 1071 - 1073 - Getting Into the Rhythm With CRISPR(2018)
Authors: Thierry Vandendriessche, Marinee Chuah
Pages: 928 - 930 - Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells(2018)
Authors: Yoke Chin Chai, Joris Vermeesch, Marinee Chuah, Thierry Vandendriessche
Pages: 8275 - 8298 - A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity(2018)
Authors: Thierry Vandendriessche, Marinee Chuah
Pages: 927 - 937 - Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9(2018)
Authors: Marinee Chuah, Thierry Vandendriessche
Pages: 1241 - 1254 - Haemophilia gene therapy: From trailblazer to gamechanger(2018)
Authors: Marinee Chuah, Thierry Vandendriessche
Pages: 50 - 59 - Identification of New Muscle-Tropic Adeno-Associated Virus (AAV) Capsids for Treatment of Rare Hereditary Muscular Disorders(2018)
Authors: Jihad El Andari, Warut Tulalamba, Jonas Weinmann, Thierry Vandendriessche, Marinee Chuah, Dirk Grimm
Pages: 43 - 44 - Biopotency and Efficacy of SHP648, a Next-Generation Fix Gene Therapy Vector(2018)
Authors: Markus Weiller, Maria Schuster, Sogue Coulibaly, Herbert Gritsch, Kefeng Sun, Thierry Vandendriessche, Marinee Chuah, Hanspeter Rottensteiner, Werner Hoellriegl
Pages: 375 - 375 - Hyperactive Factor IX Padua: A Game-Changer for Hemophilia Gene Therapy(2018)
Authors: Thierry Vandendriessche, Marinee Chuah
Pages: 14 - 16 - Development of SHP648, Shire's high performing AAV8-based FIX gene therapy vector(2017)
Authors: Thierry Vandendriessche
Pages: A18 - A18
Patents
1 - 1 of 1